Abstract
Aims This study aimed to develop a deep-learning algorithm to enable a fully-automated analysis and interpretation of optical coherence tomography (OCT) pull-backs from patients after percutaneous coronary intervention (PCI).
Methods and results In 1148 frames from 92 OCTs, neointima was manually classified as homogeneous, heterogenous, neoatherosclerosis, or not analyzable at quadrant level by an experienced expert. Additionally, stent and lumen contours were annotated in 90 frames to enable segmentation of lumen, stent struts and neointima. Annotated frames were used to train “DeepNeo”, a deep learning tool for prediction of neointimal tissue characteristics. Performance of DeepNeo was additionally evaluated in an animal model of neoatherosclerosis, using co-registered histopathology images as the gold-standard. DeepNeo demonstrated excellent classification performance of neointimal tissue with an overall accuracy of 75%, comparable to manual classification accuracy of two clinical experts (75%, 71%). The accurate performance of DeepNeo was confirmed in an animal model of neoatherosclerosis, where an overall accuracy of 87% was achieved. Segmentation of lumen, stent struts and neointima in human pullbacks yielded very good performance with mean Dice overlap scores of 0.99, 0.66 and 0.86.
Conclusion DeepNeo is the first deep learning algorithm allowing fully automated segmentation and classification of neointimal tissue, with a performance comparable to human experts. DeepNeo might ultimately help assess vascular healing after percutaneous coronary intervention in a standardized, reliable and time-efficient manner, support therapeutic decisions and improve the detection of patients at risk of future cardiac events.
Competing Interest Statement
T.K. is named inventor on a patent application for prevention of restenosis after angioplasty and stent implantation outside the submitted work. T.K. received lecture fees from Bayer, Abbott, Bristol-Myers-Squibb and Astra-Zeneca which are unrelated to this work. All other authors declare that they have no conflict of interest.
Funding Statement
This work was supported through a scientific grant by the German Cardiac Society (Grant Number: 16/2020) and by the Helmholtz Association under the joint research school "Munich School for Data Science - MUDS". It was also supported by the BMBF-funded de.NBI Cloud within the German Network for Bioinformatics Infrastructure (de.NBI) (031A532B, 031A533A, 031A533B, 031A534A, 031A535A, 031A537A, 031A537B, 031A537C, 031A537D, 031A538A). C.M. has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement number 866411). T.K. received funding from the German Research Foundation (DFG) as part of a research project (KE 2116/4-1) and the Heisenberg program (KE 2116/5-1). Additional funding was received from the Translation & Innovation grant from Helmholtz Munich.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been approved by the ethical board of Technical University of Munich, Germany in accordance with local regulations (Nr. 2023-143-S-NP).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying this article will be shared on reasonable request to the corresponding authors.